RECENT ADVANCES IN ALZHEIMER'S DISEASE: CAUSES AND TREATMENT

Abstract

Alzheimer’s disease (AD) is a destructive neurodegenerative disorder characterized by progressive memory defeat and impairment in behavior, language, and visuospatial skills. Neuropsychiatric symptoms such as apathy, depression, aggression, agitation, sleep disruption, and psychosis are now recognized as core symptoms of AD that are expressed to varying degrees throughout the course of disease. The neuro pathological features of AD comprise extracellular senile plaques constituted of β-amyloid (Aβ) pledges, intracellular neurofibrillary tangles (NFTs), and cerebral atrophy; others include apolipoprotein E, oxidative stress, mitochondrial dysfunction and cholinergic hypothesis. Anti-amyloid therapy is available for the treatment of Alzheimer’s disease, others are anticholinergic therapy, and therapy for mitochondrial dysfunction, γ-secretase inhibitors (GSI) and modulators (GSM), 𝛽-secretase (BACE1) inhibitors, Glial modulating drugs includes RAGE receptor antagonists, TNF-α antagonists, neuroprotective drugs such as antioxidants, phosphodiesterase inhibitors, PPARγ agonists, and anti-tau or tau modulators like microtubule stabilizers, kinase inhibitors. This review includes discussion on neurobiological mechanisms and newly developed compounds which have lesser side effects and are proving more efficient for treatment of Alzheimer’s disease. 

Authors and Affiliations

Kiranjit Kaur, Rajneet Kaur, Manjinder Kaur

Keywords

Related Articles

SYNTHESIS, SPECTRAL CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF NOVEL 2-HYDRAZONO-2(3H)-THIAZOLE DERIVATIVES DERIVED FROM 4-(3-CHLOROPHENYL)-3-THIOSEMICARBAZIDE

Objective: A series of substituted 2-hydrazono-2(3H)-thiazole derivatives were synthesized from 4-(3-chlorophenyl)-3-thiosemicarbazide and evaluated in vitro for antimicrobial activity against Escherichia coli, Candida a...

MOLECULAR DOCKING STUDY OF NEUROPROTECTIVE PLANT-DERIVED BIOMOLECULES IN PARKINSON’S DISEASE

Objective: The objective of this study was to explore the therapeutic role of biomolecules in targeting the altered expression of Parkin in PD pathogenesis.Methods: We employed various in silico tools such as drug-likene...

THE RELATION BETWEEN INTERNET, DEPRESSION, SELF-ESTEEM AND SOCIAL ATTACHMENT ON COGNITIVE FUNCTION OF HEALTH CARE INDIVIDUALS

Objective: To assess the internet use in health care individuals and its impact on depression, self-esteem and social attachment on cognitive function of health care individuals.Methods: This was a cross-sectional survey...

IN VITRO ANTIPLASMODIAL AND CYTOTOXIC ACTIVITIES OF A SUNGKAI (PERONEMA CANESCENS) LEAF EXTRACT

Objective: The aim of this study was to assess the antiplasmodial and cytotoxic activities and to evaluate the selectivity indices of acetone, ethanol and aqueous extracts of Peronema canescens leaves.Methods: Antiplasmo...

IN VITRO EVALUATION OF DISSOLUTION PROFILE OF TWO COMMERCIALLY AVAILABLE FOLIC ACID PREPARATIONS

Objectives: Folic acid is a water-soluble B vitamin that is naturally present in some foods such as dark green leafy vegetables and dairy products, added to others such as fortified breads, and available as a dietary sup...

Download PDF file
  • EP ID EP577835
  • DOI -
  • Views 94
  • Downloads 0

How To Cite

Kiranjit Kaur, Rajneet Kaur, Manjinder Kaur (2016). RECENT ADVANCES IN ALZHEIMER'S DISEASE: CAUSES AND TREATMENT. International Journal of Pharmacy and Pharmaceutical Sciences, 8(2), 8-15. https://europub.co.uk/articles/-A-577835